QLB Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- QLB Biotherapeutics's estimated annual revenue is currently $1.1M per year.
- QLB Biotherapeutics's estimated revenue per employee is $155,000
Employee Data
- QLB Biotherapeutics has 7 Employees.
- QLB Biotherapeutics grew their employee count by 0% last year.
QLB Biotherapeutics's People
Name | Title | Email/Phone |
---|
QLB Biotherapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is QLB Biotherapeutics?
QLB Biotherapeutics Inc., located in Boston, Massachusetts, is a startup biotechnology company focusing on discovering and developing biological therapeutics. QLB Bio is funded by Qilu Pharmaceutical, and will become its biggest overseas Research and Development Center. QLB Bio is devoted to developing next-generation cancer therapeutics using the transformative potential of immunotherapy. We have an ambitious vision and a growing pipeline of novel cancer immunotherapy biological candidates to treat solid tumors as well as hematologic cancers. To achieve our mission, we seek highly motivated professionals who share our dedication to patients and our passion for discovery, innovation and scientific rigor.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.8M | 7 | -22% | N/A |
#2 | $0.1M | 7 | 0% | $25M |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.5M | 7 | N/A | N/A |
#5 | $0.1M | 7 | 0% | $3.1M |